Inner Mongolia Furui Medical Science Co., Ltd. (SHE: 300049)

Inner Mongolia Furui Medical Science Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,265	1,147	1,001	891.56	800.96	824.38
Other Revenue	6.42	6.9	7.37	6.93	6.57	7.36
Revenue	1,272	1,154	1,009	898.48	807.53	831.74
Revenue Growth (YoY)	17.31%	14.37%	12.27%	11.26%	-2.91%	-4.07%
Cost of Revenue	329.35	291.39	267.67	239.14	226.65	239.06
Gross Profit	942.53	862.34	741.09	659.34	580.88	592.68
Selling, General & Admin	547.84	527.56	474.49	405.7	361.47	388.55
Research & Development	95.53	82.47	70.82	64.79	65.82	60.75
Other Operating Expenses	12.74	10.43	10.79	12.5	11.39	11.74
Operating Expenses	670.54	617.39	562.68	491.94	440.51	450.22
Operating Income	271.99	244.95	178.41	167.4	140.38	142.45
Interest Expense	-0.98	-0.9	-1.58	-2.33	-3.21	-2.97
Interest & Investment Income	6.19	12.39	9.73	10.54	3.41	0.72
Currency Exchange Gain (Loss)	8.55	-2.32	7.93	16.48	-12.48	2.88
Other Non Operating Income (Expenses)	5.57	-0.53	-1.28	-0.26	-0.25	-0.69
EBT Excluding Unusual Items	291.32	253.59	193.21	191.83	127.84	142.4
Gain (Loss) on Sale of Investments	-5.56	-	-	-	-1.6	-15.63
Gain (Loss) on Sale of Assets	-0.24	-0.82	-1.86	-3.46	-6.93	0.01
Asset Writedown	-4.71	-4.71	-0	-	-	-0.07
Other Unusual Items	-13.4	-12.66	0.29	0.77	-5.32	-0.07
Pretax Income	268.17	235.4	191.63	189.14	113.99	126.64
Income Tax Expense	57.48	58.29	46.22	41.1	23.72	26.52
Earnings From Continuing Operations	210.69	177.11	145.41	148.04	90.27	100.13
Minority Interest in Earnings	-77.58	-75.55	-47.52	-52.57	-28.36	-56.74
Net Income	133.11	101.56	97.89	95.47	61.91	43.39
Net Income to Common	133.11	101.56	97.89	95.47	61.91	43.39
Net Income Growth	21.94%	3.75%	2.54%	54.22%	42.69%	22.50%
Shares Outstanding (Basic)	263	263	263	260	256	256
Shares Outstanding (Diluted)	263	263	263	260	256	256
Shares Change (YoY)	0.02%	-0.01%	1.30%	1.31%	0.03%	-5.93%
EPS (Basic)	0.51	0.39	0.37	0.37	0.24	0.17
EPS (Diluted)	0.51	0.39	0.37	0.37	0.24	0.17
EPS Growth	21.92%	3.76%	1.22%	52.22%	42.65%	30.23%
Free Cash Flow	85.23	115.66	98.69	142.94	90.41	189.93
Free Cash Flow Per Share	0.32	0.44	0.38	0.55	0.35	0.74
Dividend Per Share	-	-	0.200	-	-	-
Gross Margin	74.11%	74.74%	73.47%	73.38%	71.93%	71.26%
Operating Margin	21.38%	21.23%	17.69%	18.63%	17.38%	17.13%
Profit Margin	10.47%	8.80%	9.70%	10.63%	7.67%	5.22%
Free Cash Flow Margin	6.70%	10.02%	9.78%	15.91%	11.20%	22.84%
EBITDA	344.91	312.12	236.39	221.12	209.72	193.45
EBITDA Margin	27.12%	27.05%	23.43%	24.61%	25.97%	23.26%
D&A For EBITDA	72.92	67.18	57.98	53.71	69.35	50.99
EBIT	271.99	244.95	178.41	167.4	140.38	142.45
EBIT Margin	21.38%	21.23%	17.69%	18.63%	17.38%	17.13%
Effective Tax Rate	21.43%	24.76%	24.12%	21.73%	20.81%	20.94%
Revenue as Reported	1,272	1,154	1,009	898.48	807.53	831.74
Advertising Expenses	-	4.76	9.83	9.3	5.62	6.94

Source: S&P Capital IQ. Standard template. Financial Sources.